Vitiligo Skin Transplantation

Completed · Phase 3

Conditions studied: Vitiligo

In brief

In vitiligo, the melanocytes are lost from the skin in certain areas. One treatment for vitiligo takes the melanocytes from areas of normal skin and places them on areas of that same person's body which have lost their color. This is called the melanocyte-keratinocyte transplantation procedure (MKTP). This procedure has been used successfully in over 3000 cases in India and Saudi Arabia. The purpose of this study is to see if it is effective when performed at the investigators' institution.

Key facts

Study ID

NCT00830713

Run by

Henry Ford Health System

People needed

40

Starts

2009-01-01

Expected to finish

2011-10-01

Last updated by the study team

2012-09-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be at least 18 years old
• Have a diagnosis of vitiligo with no news lesions or growth of old lesions in the past 6 months
• Be able to understand the requirements of the study, the risks involved, and be able to sign the informed consent form
• Agree to follow and undergo all study-related procedures

You may not qualify if…

• Female patients who are breastfeeding, pregnant, or planning to become pregnant
• Patients with a history of developing vitiligo or keloids at sites of trauma
• Patients self-reported as having HIV or Hepatitis C
• Patients self-reported as having uncontrolled Diabetes Mellitus
• The investigator feels the patient should not participate in the study for any reason

Where it is running

• Henry Ford Medical Center, New Center One — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.